Brokerages Set Walgreens Boots Alliance Inc (WBA) Target Price at $85.44

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) have been assigned a consensus rating of “Buy” from the twenty-five ratings firms that are covering the firm, MarketBeat reports. Ten investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $85.65.

Several research firms have issued reports on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Needham & Company LLC restated a “buy” rating and issued a $88.00 price target (up from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a research report on Sunday. Jefferies Group restated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, October 2nd. Finally, Pivotal Research set a $73.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Friday, January 5th.

Walgreens Boots Alliance (NASDAQ WBA) traded up $0.93 during trading hours on Friday, reaching $77.40. 3,619,500 shares of the company were exchanged, compared to its average volume of 6,247,471. Walgreens Boots Alliance has a 1-year low of $63.82 and a 1-year high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The firm has a market cap of $76,300.00, a price-to-earnings ratio of 21.38, a PEG ratio of 1.29 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. During the same period last year, the business posted $1.10 EPS. Walgreens Boots Alliance’s revenue was up 7.9% compared to the same quarter last year. equities analysts anticipate that Walgreens Boots Alliance will post 5.71 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.07%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is 44.20%.

In other news, Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The stock was purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Hudock Capital Group LLC lifted its stake in Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares in the last quarter. Westside Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares in the last quarter. Zions Bancorporation lifted its position in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares in the last quarter. IHT Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 2,199 shares in the last quarter. Finally, Bristlecone Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the third quarter worth $135,000. 61.15% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Brokerages Set Walgreens Boots Alliance Inc (WBA) Target Price at $85.44” was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.truebluetribune.com/2018/01/23/brokerages-set-walgreens-boots-alliance-inc-wba-target-price-at-85-44.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply